Zepp Health Corporation Sponsored ADR $ZEPP Shares Sold by Trivest Advisors Ltd

Trivest Advisors Ltd cut its position in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) by 44.8% in the fourth quarter, Holdings Channel reports. The firm owned 162,904 shares of the company’s stock after selling 132,043 shares during the period. Zepp Health accounts for approximately 0.2% of Trivest Advisors Ltd’s holdings, making the stock its 28th biggest position. Trivest Advisors Ltd’s holdings in Zepp Health were worth $4,389,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ZEPP. Millennium Management LLC acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $11,265,000. UBS Group AG boosted its position in shares of Zepp Health by 16,412.0% in the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock valued at $8,300,000 after purchasing an additional 180,204 shares during the period. Keystone Investors PTE Ltd. acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $4,811,000. Lighthouse Investment Partners LLC acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $2,070,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $1,895,000. 52.61% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Fundamental Research set a $56.28 price objective on Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $56.28.

Zepp Health Stock Performance

Shares of ZEPP stock opened at $6.14 on Friday. The stock has a fifty day moving average price of $12.04 and a 200 day moving average price of $19.56. The stock has a market cap of $90.06 million, a PE ratio of -2.44 and a beta of 1.78. Zepp Health Corporation Sponsored ADR has a 1 year low of $2.25 and a 1 year high of $61.85. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.77 and a current ratio of 1.02.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.